Literature DB >> 21829418

Dapsone hypersensitivity syndrome causing disseminated intravascular coagulation.

Melanie Clare Figtree1, Spiros Miyakis, Kumiko Tanaka, Linda Martin, Pam Konecny, Steven Krilis.   

Abstract

Dapsone hypersensitivity syndrome is an idiosyncratic reaction to this drug and can present with different clinical manifestations of varying severity. We describe a patient with disseminated intravascular coagulation (DIC) as an adverse reaction to dapsone. To the best of our knowledge, this is the first time it has been described in the literature. She presented with fever, rash and abdominal pain; she also had marked eosinophilia and features suggestive of oxidative haemolysis. Her course was complicated by DIC, splenic infarction and gastrointestinal bleeding. Extensive investigations did not reveal any alternative aetiology. She was initially treated with supportive measures and folic acid; steroids were administered later, following clinical deterioration. There was gradual improvement and the steroids were tapered. The patient recovered fully and remains well; her underlying chronic dermatologic condition is under satisfactory control with other medications.

Entities:  

Year:  2009        PMID: 21829418      PMCID: PMC3030115          DOI: 10.1136/bcr.11.2008.1257

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  5 in total

1.  Development of dapsone toxicity in patients with inflammatory dermatoses: activity of acetylation and hydroxylation of dapsone as risk factors.

Authors:  R E Bluhm; A Adedoyin; D G McCarver; R A Branch
Journal:  Clin Pharmacol Ther       Date:  1999-06       Impact factor: 6.875

2.  Increased incidence in leprosy of hypersensitivity reactions to dapsone after introduction of multidrug therapy.

Authors:  J H Richardus; T C Smith
Journal:  Lepr Rev       Date:  1989-12       Impact factor: 0.537

3.  Mortality due to dapsone hypersensitivity syndrome complicating multi-drug therapy for leprosy in Nepal.

Authors:  B Pandey; K Shrestha; J Lewis; R A Hawksworth; S L Walker
Journal:  Trop Doct       Date:  2007-07       Impact factor: 0.731

4.  A multicenter, prospective validation of disseminated intravascular coagulation diagnostic criteria for critically ill patients: comparing current criteria.

Authors:  Satoshi Gando; Toshiaki Iba; Yutaka Eguchi; Yasuhiro Ohtomo; Kohji Okamoto; Kazuhide Koseki; Toshihiko Mayumi; Atsuo Murata; Toshiaki Ikeda; Hiroyasu Ishikura; Masashi Ueyama; Hiroshi Ogura; Shigeki Kushimoto; Daizoh Saitoh; Shigeatsu Endo; Shuji Shimazaki
Journal:  Crit Care Med       Date:  2006-03       Impact factor: 7.598

5.  The Dapsone hypersensitivity syndrome revisited: a potentially fatal multisystem disorder with prominent hepatopulmonary manifestations.

Authors:  Semaan G Kosseifi; Bhuvana Guha; Dima N Nassour; David S Chi; Guha Krishnaswamy
Journal:  J Occup Med Toxicol       Date:  2006-06-06       Impact factor: 2.646

  5 in total
  2 in total

1.  Drug-Induced Hypersensitivity Syndrome (DIHS)/Drug Reaction With Eosinophilia and Systemic Symptoms (DRESS): Clinical Features and Pathogenesis.

Authors:  Natsumi Hama; Riichiro Abe; Andrew Gibson; Elizabeth J Phillips
Journal:  J Allergy Clin Immunol Pract       Date:  2022-02-15

2.  Daclatasvir and Asunaprevir Combination Therapy-induced Hepatitis and Cholecystitis with Coagulation Disorder due to Hypersensitivity Reactions.

Authors:  Yuichi Miyashima; Yuichi Honma; Koichiro Miyagawa; Shinji Oe; Michio Senju; Michihiko Shibata; Masaaki Hiura; Shintaro Abe; Masaru Harada
Journal:  Intern Med       Date:  2016-12-15       Impact factor: 1.271

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.